Dr Das on the Use of Neoadjuvant and Adjuvant Chemoimmunotherapy Regimens in NSCLC

Devika Das, MD, MSHQS, discusses the use of neoadjuvant and adjuvant chemoimmunotherapy for patients with resectable non–small cell lung cancer, and emphasizes the importance of multidisciplinary collaboration when incorporating these regimens into treatment approaches.

Related Keywords

Devika Das ,University Of Alabama At Birmingham ,Lung Cancer ,Chemoimmunotherapy ,Non Small Cell Lung Cancer ,Adjuvant ,Neoadjuvant ,